The SARS‐CoV‐2 Omicron (B.1.1.529) variant and the re‐emergence of COVID‐19 in Europe: An alarm for Bangladesh

The SARS‐CoV‐2 Omicron (B.1.1.529) variant and the re‐emergence of COVID‐19 in Europe: An alarm for Bangladesh

Bibliographic Details
Main Author:	Md. Rabiul Islam
Format:	Article
Language:	English
Published:	Wiley 2022-03-01
Series:	Health Science Reports
Online Access:	https://doi.org/10.1002/hsr2.545

Similar Items

Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
by: Md. Rabiul Islam, et al.
Published: (2022-09-01)

First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
by: A. Carrazco-Montalvo, et al.
Published: (2022-01-01)

Havoc caused by the SARS-CoV-2 Omicron (B.1.1.529)
by: Prithiviraj Nagarajan, et al.
Published: (2022-07-01)

SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
by: Zeinab Mohseni Afshar, et al.
Published: (2023-02-01)

SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection
by: Zeev Elkoshi
Published: (2022-03-01)

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)
by: June Young Chun, et al.
Published: (2022-11-01)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
by: Dejnirattisai, W, et al.
Published: (2021)

The Omicron (B.1.1.529) SARS-CoV-2 variant of concern also affects companion animals
by: Lidia Sánchez-Morales, et al.
Published: (2022-08-01)

Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529)
by: Si Qin, et al.
Published: (2021-11-01)

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
by: Wenlin Ren, et al.
Published: (2023-04-01)

Stability Analysis of B.1.1.529 SARS-Cov-2 Omicron Variant Mathematical Model: The Impacts Of Quarantine And Vaccination
by: Dickson S., et al.
Published: (2022-12-01)

Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing
by: Lasse D. Rasmussen, et al.
Published: (2022-06-01)

A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
by: R Manjunath, et al.
Published: (2022-09-01)

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
by: Lu Y, et al.
Published: (2023-01-01)

Multi-layer SPR biosensor for in-Situ Amplified monitoring of the SARS-CoV-2 omicron (B.1.1.529) variant
by: Tarik Bin Abdul Akib, et al.
Published: (2024-02-01)

A Novel Probiotic-Based Oral Vaccine against SARS-CoV-2 Omicron Variant B.1.1.529
by: Eddie Chung Ting Chau, et al.
Published: (2023-09-01)

Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa
by: Hiroshi Nishiura, et al.
Published: (2021-12-01)

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
by: Camilla Mattiuzzi, et al.
Published: (2022-05-01)

The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
by: HyokJu Ri, et al.
Published: (2022-03-01)

Differentiating the SARS-CoV-2 Omicron (B.1.1.529) variant from other COVID-19 variants of concerns and the common cold
by: Chetan Dixit, et al.
Published: (2022-01-01)

Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529)
by: Akiko Yonekawa, et al.
Published: (2022-03-01)

Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
by: Sapna Sharma, et al.
Published: (2022-11-01)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
by: Chiranjib Chakraborty, et al.
Published: (2023-03-01)

Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01)

Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
by: Melanie Rissmann, et al.
Published: (2022-12-01)

Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
by: Qian Wang, et al.
Published: (2022-06-01)

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
by: Dejnirattisai, W, et al.
Published: (2022)

Clinical Characteristics of Children Infected with SARS-CoV-2 Omicron (B.1.1.529) in China’s Shanghai
by: Shu J, et al.
Published: (2024-01-01)

In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
by: Franck Touret, et al.
Published: (2022-03-01)

Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages
by: Mukul Jain, et al.
Published: (2022-10-01)

A comparative study of spike protein of SARS-CoV-2 and its variant Omicron (B.1.1.529) on some immune characteristics
by: Ximeng Li, et al.
Published: (2022-10-01)

Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay
by: Chiara Ippoliti, et al.
Published: (2022-08-01)

Spike protein of SARS‐CoV‐2 Omicron (B.1.1.529) variant have a reduced ability to induce the immune response
by: Cai He, et al.
Published: (2022-04-01)

Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
by: Andrés Carrazco-Montalvo, et al.
Published: (2022-05-01)

Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of omicron (B1.1.529) pseudovirus
by: Xu Cao, et al.
Published: (2024-04-01)

SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City
by: Kurt J. Vandegrift, et al.
Published: (2022-12-01)

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
by: Haifa Khemiri, et al.
Published: (2022-09-01)

High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children
by: Hiroshi Nishiura, et al.
Published: (2022-09-01)

Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529).
by: Ali Qureshi, et al.
Published: (2022-01-01)

A study on the effect of natural products against the transmission of B.1.1.529 Omicron
by: Samar Sami Alkafaas, et al.
Published: (2023-08-01)